The global clinical trial packaging market size was valued at USD 3.49 billion in 2025 and is projected to grow from USD 3.81 billion in 2026 to USD 7.73 billion by 2034, registering a CAGR of 9.24% during the forecast period (2026-2034). North America dominated the clinical trial packaging market with a share of 38.09% in 2025.
Clinical trial packaging ensures that investigational drugs, placebos, comparator medicines, and other study treatments are securely packaged, correctly identified, traceable, and maintained under specified storage and handling conditions throughout the clinical development process. It is tracked under HSN Code 3923 (articles for the conveyance or packing of goods, of plastics) and SIC Code 2671 (packaging paper and plastics film, coated and laminated).
The clinical trial packaging market demand is driven by the development of investigational drugs and the need for accurate labeling and secure packaging of trial materials. Pharmaceutical companies use temperature-controlled solution and patient-specific packaging, contributing to clinical trial packaging market growth.
Download a Free Sample To learn more about this report,
Adaptive Packaging Formats for Blinded Clinical Trials
The clinical trial packaging market analysis shows a shift toward packaging formats that preserve treatment blinding across clinical study groups. Over-encapsulation, matched labels, and visually identical packaging can help conceal differences between active medicines and placebos. These methods allow trial sponsors to maintain treatment masking while accommodating different dosage forms.
Temperature Controlled Packaging for Cell and Gene Therapy Trials
Clinical trial packaging is evolving to accommodate investigational cell and gene therapies that require strict temperature control. Specialized insulated shippers, cryogenic containers, and temperature-monitoring devices help maintain product stability during transport to clinical sites. These packaging systems support the handling of sensitive biological therapies throughout trial distribution.
Supply chain disruptions are expected to have a moderate impact on the clinical trial packaging market share, given its direct exposure to shortages of specialized packaging materials, pharmaceutical-grade containers, and labeling components. The market is expected to experience a capacity-constrained recovery, as limited availability of compliant packaging materials and specialized production capacity can delay clinical trial shipments. The market is projected to grow at a CAGR of 9.24%, but supply chain constraints could reduce growth by 1.5 percentage points, resulting in a growth of around 7.74%. As supply conditions normalize, the clinical trial packaging market growth is expected to gradually return to 9.24%.
The clinical trial packaging market forecasts strategic investment activity directed toward investigational drug packaging, clinical supply services,and sterile packaging systems. In April 2026, PCI Pharma Services announced infrastructure investments exceeding USD 1 billion across its United States and European operations. The investment program includes sterile fill-finish lines, drug-device assembly and packaging, and capabilities supporting clinical trial supply.
Demand for Patient-Centric Packaging Solutions and Expansion of Decentralized Clinical Trials Drives Market
Demand for patient-centric packaging solutions is growing as clinical trials focus on making medication easier for participants to use. Packaging with clear instructions, simple opening features, and organized dose schedules can help patients follow treatment plans more effectively. This focus on patient convenience is supporting the clinical trial packaging market.
The expansion of decentralized clinical trials is increasing demand for packaging that supports direct delivery of study medications to participants. These trials often require secure packaging, clear labeling, and temperature control to maintain drug quality during shipping. The use of remote participation is supporting demand for specialized clinical trial packaging solutions.
Frequent Protocol Amendments and Blinding Requirements Restrain Market Expansion
Changes in clinical trial protocols can require packaging vendors to revise labels, kit contents, dosage configurations, and shipment quantities after production has started. These revisions can result in repackaging, material wastage, and delivery delays, which may limit operational efficiency and slow trial execution.
Maintaining treatment blinding requires strict control over packaging appearance, labeling, and product allocation across trial groups. These requirements can complicate packaging workflows and increase the risk of unblinding errors, which may lead to additional quality checks and restrict the flexibility of clinical trial packaging operations.
Packaging for Just in Time Radiopharmaceutical Trials and Reusable Packaging Intelligence Systems Create Opportunities for Market Players
Radiopharmaceutical trials create a specialized opportunity for packaging providers because some investigational products have short usable lifetimes due to radioactive decay. Companies can develop packaging workflows that coordinate shielding, dose identification, time-sensitive dispatch, and delivery to clinical sites. These services can help trial sponsors manage tightly scheduled treatment windows and reduce product loss during transport.
Reusable packaging intelligence systems offer another distinctive opportunity for clinical trial packaging providers. Smart shipping containers can record temperature excursions, opening events, location, and handling conditions across multiple shipments. Packaging companies can combine these records with digital chain-of-custody systems to help sponsors investigate shipment deviations, document returns, and improve accountability for high-value investigational medicines.
Plastic accounted for the largest share of 44.26% in 2025, owing to its lightweight structure, versatility, and suitability for packaging clinical trial supplies across different dosage forms.
Paper and corrugated fiber is expected to grow at a CAGR of 10.14% during the forecast period, fueled by their use in secondary packaging, protective shipping boxes, and clinical trial distribution materials. Their role in organizing and protecting investigational medicinal products (IMP) packaging also supports segment growth.
Request Customizationto receive a tailored report.
Vials and ampoules accounted for a significant share in 2025, supported by their use in packaging liquid and injectable investigational medicines that require secure containment and protection.
The syringes segment is projected to undergo growth of 10.12% during the forecast period, as flexible packaging formats support the storage and distribution of selected clinical trial products. Their adaptable design can also help accommodate patient-specific packaging and clinical supply requirements.
Drug manufacturing companies accounted for a leading share of 42.49% in 2025, owing to their role in producing investigational medicines and coordinating packaging, labeling, and distribution for clinical studies.
The clinical research organizations segment is projected to grow at 10.42% CAGR during the forecast period. This growth is driven by pharmaceutical companies outsourcing clinical supply management, packaging, labeling, and trial distribution activities to specialized service providers.
Speak to an Analystto discuss market opportunities.
The North America clinical trial packaging market accounted for a dominant share of 38.09% in 2025.
US benefit from regulatory requirements for maintaining investigational drug quality, traceability, and treatment blinding during clinical studies. The US Food and Drug Administration’s adoption of the ICH E6(R3) Good Clinical Practice guidance emphasizes appropriate packaging, labeling, coding, and protection against contamination or deterioration during storage and transportation.
Canada’s clinical trial packaging market benefits from the country’s active clinical research environment, particularly studies involving biologics and temperature-sensitive therapies. These trials require carefully designed pharmaceutical packaging with appropriate labeling, product protection, and temperature control to maintain investigational product integrity throughout storage and distribution.
Unlock Regional Insightsto access country-level data, & regional trends.
The Asia Pacific clinical trial packaging market is expected to grow at a CAGR of 11.63% during the forecast period, making it the fastest-growing region.
Japan’s Good Clinical Practice regulations require trial sponsors to label investigational drug containers in Japanese, maintain manufacturing and quality records, and package trial medicines to prevent contamination or deterioration during transportation and storage. These requirements create opportunities for clinical packaging providers offering Japanese-language labeling, blinded packaging, tamper-evident kits, and temperature-controlled packaging for investigational drugs and biologics.
Biopharma SHAKTI initiative in India strengthes biopharmaceutical manufacturing and establish a network of more than 1,000 accredited clinical trial sites. By expanding clinical research and the development of biologics, the initiative is expected to increase demand for clinical trial packaging.
Catalent’s Shanghai clinical supply facilities provide secondary packaging, clinical trial labeling, controlled storage, and distribution services for local and multinational studies. These capabilities support drug packaging, investigational medicinal products packaging, and temperature-controlled clinical trial logistics within China.
The Europe clinical trial packaging market is likely to witness a CAGR of 8.91% during the forecast period.
Germany’s pharmaceutical packaging sector benefits from regulatory requirements designed to reduce medicine tampering and protect patients. Under the EU Falsified Medicines Directive (FMD), covered medicines must carry anti-tampering features, encouraging the use of tamper-evident packaging to maintain product security during storage and distribution.
UK clinical trial packaging market is supported by the demand for specialized packaging services as pharmaceutical and biotechnology companies advance clinical studies. For instance, Sharp’s clinical services facility expanded packaging capacity and introduced integrated services, including packaging serialization, to improve product traceability and support clinical trials from early development through later phases.
Latin America’s clinical trial packaging is projected to undergo growth at a CAGR of 9.67% during the forecast period. Brazil’s clinical research supply chain is supported by AVANTI Pesquisa Clínica, which provides clinical trial supply importation, storage, inventory management, and distribution services. These capabilities help strengthen clinical trial distribution by coordinating the movement of investigational products to research sites across the country.
Mexico’s clinical research sector is supported by specialized clinical research organizations such as INNOVARE R&D, which provides clinical trial management services for pharmaceutical and biotechnology studies. As trials require study-specific medication kits, demand for patient-specific packaging can grow to help ensure investigational products are prepared according to individual participants.
The Middle East & Africa clinical trial packaging market is anticipated to record a growth rate of 9.36% during the forecast period. UAE’s clinical research sector benefits from specialized healthcare logistics providers such as DHL Health Logistics, which supports the storage and transportation of pharmaceutical products under controlled conditions.
South Africa’s Good Pharmacy Practice rules require unit-dose medicine packaging to use materials that are waterproof, airtight, and tamper-evident.
The clinical trial packaging market competitive landscape is moderately fragmented, with established pharmaceutical packaging service providers, clinical trial supply companies, and specialized contract packaging manufacturers. Key players such as Thermo Fisher Scientific Inc., Catalent, Inc., PCI Pharma Services, Sharp Services, LLC, and Gerresheimer AG are estimated to account for 35% of the global clinical trial packaging market share.
Established players compete mainly through drug labeling, blinding services, and customized trial kits. Regional players in the clinical trial packaging market ecosystem focus on flexible batch production, cost-efficient services, and localized clinical supply support to strengthen their market presence.
October 2026: ACG launched RecycloPod PP Ultra, a recyclable polypropylene blister packaging system designed to provide moisture and oxygen protection for sensitive pharmaceutical products.
April 2026: Gerresheimer expanded its pharmaceutical packaging portfolio with silicone oil-free and PFAS-free syringe systems designed for injectable medicines and clinical applications.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Congenital Hyperinsulinism Treatment Market Size, Opportunities, 2034
Acute Kidney Injury Treatment Market Size, Forecast, Demand, 2034
Ibuprofen Market Size, Share, Growth, Analysis, Report, 2034
Cryptococcosis Market Size, Forecast, Demand, Opportunities, 2034
Apixaban Market Size, Forecast, Demand, Opportunities, 2034
Asbestosis Treatment Market Size, Forecast, Demand, 2034
We are featured on:
sales@straitsresearch.com